Sanevit Arad, the first single-use syringe factory in Romania, was sold at public auction for 1,680,000 euros, after not producing anything for over a decade. Opened in 1995, the factory had an annual capacity of 200 million syringes and 500 million medical needles, but went bankrupt in 2021, accumulating debts of approximately 8.4 million lei. The Ministry of Economy unsuccessfully tried to privatize it earlier. Recently, former employees received their outstanding salaries, with the total amount paid being approximately 1.5 million lei, the largest payment being 167,000 lei. The buyer, a Romanian company, did not specify plans for the factory and the 30,245 square meter land.
Sources
Sanevit Arad, prima fabrica de seringi din România, vândută după 10 ani cu aproape 1,7 milioane de euro
O fabrică deținută de statul român a fost vândută la licitație cu 1,7 milioane de euro. A fost prima de acest tip din România
Prima fabrică de seringi de unică folosinţă din România, Sanevit Arad, a fost vândută. De 12 ani nu a mai produs nimic
Sanevit Arad, prima fabrică de seringi de unică folosinţă din România, vândută la licitație publică / Salariile restante, plătite după mai bine de 10 ani
Prima fabrică de seringi din România a fost vândută la licitație. Angajații și-au primit salariile restante după un deceniu
Fabrica de seringi Sanevit din Arad, vândută. Foștii angajați și-au primit salariile restante după un deceniu
Latest News
16:54
The Chamber of Deputies adopted the law / Romanian athletes who won European trophies may receive merit benefits
16:49
Elections at the Romanian Academy/ The institution appointed seven new honorary members on Wednesday, following the secret ballot cast by the General Assembly
16:41
Gael Monfils, former world number 6, has reportedly retired from tennis in secret
16:27
The European Commissioner for Enlargement promised a journalist a drink if the Republic of Moldova opens all six EU clusters by the end of the year
16:17
DNA conducts searches in Constanța / Services for NATO military vessels are targeted
See more news